15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Objective: To report the recurrence, progression and survival in patients with T1G3 transitional cell carcinoma (TCC) of the urinary bladder treated with sequential intravesical bacillus Calmette-Guerin (BCG) and chemotherapeutic agents (doxorubicin or epirubicin) on long-term follow up.
著者Cheng CW, Chan SFP, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SYE, Wong WS, Lai FMM, Li ML
期刊名稱Japanese Journal of Clinical Oncology
出版年份2004
月份4
日期1
卷號34
期次4
出版社OXFORD UNIV PRESS
頁次202 - 205
國際標準期刊號0368-2811
電子國際標準期刊號1465-3621
語言英式英語
關鍵詞BCG vaccine; bladder neoplasms; doxorubicin; epirubicin; transitional cell
Web of Science 學科類別Oncology; ONCOLOGY

上次更新時間 2020-19-10 於 02:28